Background Info
Key Speakers
• Dr Dhinagar Subramanian, Associate Director - Global Health Economics and Reimbursement, Ethicon (Johnson and Johnson)
• Graham Stokoe, Senior Faculty Board Member, World Medical Device Organisation (WMDO)
• Manolis Karamalis, Reimbursement Director, Medtronic
• Oliver Mast, Head Global Reimbursement - Diabetes Care, Roche Diagnostics
• Nathalie Verin, Health Economics Manager, Boston Scientific
• Dr Frances Sutcliffe, Associate Director, Appraisals – CHTE, The National Institute for Health and Clinical Excellence (NICE)
• Dr. Gerald Schnell, Partner, Simon-Kucher & Partners
• Dr Geoff Wilson, Reimbursement Leader, EMEA, GE Healthcare
• Dr Nigel Sansom, Lead - Global Technology Horizon Scanning, NHS National Innovation Centre
Medical devices manufacturers require a more rigorous and strategic approach to safeguard product prices and prevent competition. Innovative manufacturers that have integrated their pricing and product strategies will achieve exceptional growth and profitability in this changing environment.
Visiongain’s Pricing and Reimbursement for Medical Devices conference provides expertise on integrated pricing, reimbursement and health economics strategies, across a variety of technologies. Addressing the needs of medical technology manufacturers, health technology assessors (HTA) and diagnostics companies, the conference will feature cutting edge themes by industry experts on market-focussed intelligence and value-based models.
Take advantage of the networking opportunities and gain insights on:
• Evaluation of reimbursement mechanisms in the five major EU markets (France, Italy, Spain, Germany and UK)
• Opportunities to obtain higher reimbursement for innovative medical devices
• NICE health technology and device appraisals: Processes and people
• Developing a reimbursement strategy for introducing an innovative medical device into a prospective payment based system (DRG)
• Combining reimbursement and clinical expertise to realise clinical utility targets
• Market Access and funding for medical devices in Central Eastern Europe
• Maximising the value of CED from a device manufacturer perspective
• Assigning monetary value to innovative medical devices and diagnostic technologies
Who will attend?
VP’s, Directors, Managers, Consultants of:
• Pricing and Reimbursement
• Market Access
• Price Monitoring
• Health Economics
• Outcomes Research
• Commercial Pricing
• Finance
• International Trade and Market Policy
• Parallel Trade
• Payer Relations
• Business/Corporate Strategy
• Sales & Marketing
• Brand Management
• Operations
• Research and Development
• Regulatory Affairs
• Economics/Government/Public Affairs
• Contracts
• Legal
• Health Policy
Members of:
• Medical Devices & Diagnostic Companies
• Academics, Hospitals & Government Health Bodies
• Independent Health Economists & Patient Representatives